Study Details | To Evaluate the Safety and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants with Conditions Causing Immune Impairment |
Protocol Number | D7000C00001 |
Phase | I/III |
Therapeutic Area | Infectious Diseases |
Subject Types | With Medical Condition |
Indication | Pre-exposure Prophylaxis of COVID-19 with Immune Impairment |
Principal Investigator | A/Prof Louis Yi Ann Chai |
Investigator Product / Device | AZD5156/AZD3152 |
Sponsor | AstraZeneca AB |